Canary Cure’s Game-Changing Obesity Therapy Burns Fat and Protects Muscle
Novel siRNA Therapeutic Demonstrates Significant Fat Loss and Remarkable Lean Body Mass Preservation, and Promises Superior Adherence New York, NY, January 11, 2025 — Canary Cure Therapeutics, a pioneer in next-generation RNA therapeutics development, today announced breakthrough preclinical results for its lead candidate CCT-217, addressing two critical challenges in current obesity treatments: muscle mass loss […]
CCT-217: A Landmark Gene Silencing Therapeutic for Weight Loss That Enhances Lean Mass Composition, Reduces Visceral, Subcutaneous Fat and Restores Metabolic Health in Obesity through Browning
CCT-217 Demonstrates Significant Weight Loss and Preserves Lean Body Mass with Potential for Single or Twice-Yearly Dosing Abstract According to the CDC, between 2017 and March 2020, 41.9% of U.S. adults aged 20 and older had obesity, with 9.2% experiencing severe obesity, affecting over 100 million and 22 million adults, respectively. Obesity prevalence increased from […]
Canary’s First-in-class Dual RNAi Gene Silencing Offers a Novel Approach to Weight Loss and Metabolic Disease Management
CCT-217 Demonstrates Significant Weight Loss and Preserves Lean Body Mass with Potential for Single or Twice-Yearly Dosing New York, November 18thth, 2024 – Canary Cure, a biotechnology company focused on developing innovative RNAi therapies, today announced the results of a diet-induced-obesity (DIO) mouse study demonstrating the potential of its first-in-class dual siRNA therapy, CCT-217, to […]
Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials
First-in-Class Gene-Targeted Approach to Promote Fat-Burning, Preserve Lean Body Mass, and Enhance Metabolic Health by Harnessing the Endocannabinoid System
Canary Global Approved for Canada’s SR&ED Program for Advancing Science and Technology
Canary Global has been accepted into Canada’s SR&ED program which aims to encourage R&D work conducted for the advancement of scientific knowledge or for the purpose of achieving a technological advancement.Canary applied to be included in the program in order to advance its microRNA (miRNA) work which it began during the COVID epidemic. The company […]
